Principal Financial Group Inc. Cuts Holdings in Option Care Health, Inc. $OPCH

Principal Financial Group Inc. decreased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 3.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 450,198 shares of the company’s stock after selling 15,271 shares during the period. Principal Financial Group Inc.’s holdings in Option Care Health were worth $12,497,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Boston Partners lifted its stake in Option Care Health by 34.8% in the second quarter. Boston Partners now owns 952,299 shares of the company’s stock worth $30,311,000 after purchasing an additional 245,990 shares during the last quarter. Swedbank AB purchased a new position in shares of Option Care Health in the third quarter worth about $49,455,000. Aristides Capital LLC bought a new stake in shares of Option Care Health in the 2nd quarter valued at about $249,000. Pacer Advisors Inc. purchased a new stake in Option Care Health during the 3rd quarter valued at about $593,000. Finally, Prudential Financial Inc. grew its position in Option Care Health by 32.6% during the 2nd quarter. Prudential Financial Inc. now owns 396,158 shares of the company’s stock worth $12,867,000 after acquiring an additional 97,465 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on OPCH. Stephens raised Option Care Health to a “strong-buy” rating in a research note on Thursday, December 11th. Barrington Research increased their price target on shares of Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research report on Friday, January 16th. National Bank Financial set a $37.00 price target on shares of Option Care Health in a report on Tuesday, January 27th. TD Cowen reaffirmed a “hold” rating on shares of Option Care Health in a research note on Tuesday, January 27th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and an average target price of $37.46.

Option Care Health Trading Up 4.6%

Shares of OPCH opened at $34.67 on Thursday. The firm’s 50-day moving average price is $33.41 and its 200-day moving average price is $30.10. The firm has a market capitalization of $5.50 billion, a price-to-earnings ratio of 27.52, a PEG ratio of 1.98 and a beta of 0.84. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. Option Care Health, Inc. has a 1-year low of $24.24 and a 1-year high of $36.80.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.